Optimizing Surgical and Prosthetic Workflow for Implant-supported Ear and Nose Prostheses With Early Loading and Distant Prosthesis Fabrication: A Prospective Cohort Study
Launched by UNIVERSITY HOSPITAL, GHENT · Jul 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help patients with facial defects, specifically in the nose and ear areas. These defects can happen due to injuries, cancer treatment, or birth conditions. Traditionally, after placing implants in the bone, it takes about 3-6 months before a prosthesis (a replacement part) can be attached. This study aims to shorten that waiting time to less than a month, allowing patients to receive their nose or ear prosthesis much sooner. Additionally, instead of needing to travel frequently to meet with a prosthetist, the prosthesis will be made remotely, which should make the process easier for patients.
To be eligible for this trial, participants must be adults who have facial defects in the nose or ear area that cannot be repaired with their own tissue, and they should be able to come to the hospital once a week for six weeks. However, individuals with insufficient bone for the implants, those who prefer surgery to use their own tissue, or those who cannot tolerate general anesthesia will not be included. Participants can expect regular follow-ups during the study and will be asked about their experiences and the appearance of their prosthesis to ensure it meets their needs and expectations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients with a facial defect in the nasal and/or temporal area that will not be repaired with autologous tissue;
- • Adult patients receiving oncological resection or trauma resulting in a facial defect in the nose and/or ear that will not be repaired with autologous tissue;
- • Patients who can come to the hospital every week for 6 weeks.
- Exclusion Criteria:
- • Patients with insufficient bone mass for implant placement
- • Patients who cannot come to the hospital for weekly follow-ups
- • Patients that wish an autologous reconstruction
- • Patient is unable to tolerate general anesthesia
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported